These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21747380)

  • 1. In defense of life sciences venture investing.
    Booth BL; Salehizadeh B
    Nat Biotechnol; 2011 Jul; 29(7):579-83. PubMed ID: 21747380
    [No Abstract]   [Full Text] [Related]  

  • 2. Stelios Papadopoulos.
    Papadopoulos S
    Nat Biotechnol; 2011 Mar; 29(3):184. PubMed ID: 21390003
    [No Abstract]   [Full Text] [Related]  

  • 3. Life sciences: all jazzed up.
    Mascarelli A
    Nature; 2012 Jun; 486(7403):429-31. PubMed ID: 22730564
    [No Abstract]   [Full Text] [Related]  

  • 4. Start-ups: A sense of enterprise.
    Savage N
    Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
    [No Abstract]   [Full Text] [Related]  

  • 5. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed results in Q1.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
    [No Abstract]   [Full Text] [Related]  

  • 7. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 8. US venture capital for biotechnology.
    Dibner MD; Trull M; Howell M
    Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144
    [No Abstract]   [Full Text] [Related]  

  • 9. On the biotech block.
    Ossola A
    Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
    [No Abstract]   [Full Text] [Related]  

  • 10. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 11. 2006: a stellar year for financing.
    Lawrence S
    Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738
    [No Abstract]   [Full Text] [Related]  

  • 12. America's 100 fastest-growing companies.
    Teitelbaum RS
    Fortune; 1995 Apr; 131(7):74-6, 80, 84 passim. PubMed ID: 10144014
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene patents and capital investment. The consequences of the revocation of Myriad's patents on the BRCA genes on venture capital investment in the life sciences.
    Wolinsky H
    EMBO Rep; 2013 Oct; 14(10):871-3. PubMed ID: 24030279
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from America's fastest-growing companies.
    Serwer AE
    Fortune; 1994 Aug; 130(3):42-5, 48-51, 54 passim. PubMed ID: 10136037
    [No Abstract]   [Full Text] [Related]  

  • 15. Venture capital for the pharmacologist.
    Miller LG
    Mol Interv; 2001 Dec; 1(5):242-4. PubMed ID: 14993362
    [No Abstract]   [Full Text] [Related]  

  • 16. Mile-high dreams.
    Cassiday L; Russo G
    Nature; 2010 Jul; 466(7302):146-7. PubMed ID: 20681064
    [No Abstract]   [Full Text] [Related]  

  • 17. Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases.
    Blair JC
    Retina; 2005 Dec; 25(8 Suppl):S105-S108. PubMed ID: 16374312
    [No Abstract]   [Full Text] [Related]  

  • 18. Technology and financing strategies in the development of life science companies.
    Gertler JP; Hu A; Simon J
    Surgery; 2008 Feb; 143(2):198-205. PubMed ID: 18242336
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of angels in starting a US biotech venture.
    Sohl J
    Nat Biotechnol; 2005 Feb; 23(2):263-4. PubMed ID: 15724275
    [No Abstract]   [Full Text] [Related]  

  • 20. Gary Pisano.
    Pisano G
    Nat Biotechnol; 2011 Mar; 29(3):183. PubMed ID: 21390002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.